No insider purchase over the last 90 days. The latest, by 셀트리온, was filed 10 Apr 2026.
Who traded when
BuySale+4 other insiders
Since the insiders bought
- -33.7%Entry ₩55,300 · Close 30 Oct 2026 ₩36,650
- -33.2%Entry ₩54,900 · Close 30 Oct 2026 ₩36,650
- -33.2%Entry ₩54,900 · Close 30 Oct 2026 ₩36,650
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 483,572 shares1.32% mcap100.0% of flowKRXDART:20260410003225Canonical exit: 22 Jun 2026 (T+90)
- 478,749 sharesShareKRXDART:20260410003220Canonical exit: 22 Jun 2026 (T+90)
- 8 shares@ ₩500.000.0000% mcap100.0% of flowShareKRXDART:20260403003148Canonical exit: 22 Jun 2026 (T+90)
- 105 shares@ ₩500.000.0000% mcap100.0% of flowShareKRXDART:20260403003030Canonical exit: 22 Jun 2026 (T+90)
- 165 shares@ ₩500.000.0000% mcap100.0% of flowShareKRXDART:20260403003087Canonical exit: 22 Jun 2026 (T+90)
- 191 shares@ ₩500.000.0000% mcap100.0% of flowShareKRXDART:20260403003049Canonical exit: 22 Jun 2026 (T+90)
- 45 shares@ ₩500.000.0000% mcap100.0% of flowShareKRXDART:20260403003130Canonical exit: 22 Jun 2026 (T+90)
- 117 shares@ ₩500.000.0000% mcap100.0% of flowShareKRXDART:20260403003112Canonical exit: 22 Jun 2026 (T+90)
- 114 shares@ ₩500.000.0000% mcap100.0% of flowShareKRXDART:20260403003066Canonical exit: 22 Jun 2026 (T+90)
- 6,066 sharesShareKRXDART:20260226005063
- ●Executives0DART
- 762 sharesShareKRXDART:20260205000433Canonical exit: 6 May 2026 (T+90)
- 4,651 sharesShareKRXDART:20250507000440Canonical exit: 5 Aug 2025 (T+90)
- 1,174,679 sharesKRXDART:20250410002331Canonical exit: 23 Jun 2025 (T+90)
- 1,139,880 sharesShareKRXDART:20250410002324Canonical exit: 9 Jul 2025 (T+90)
- 173 sharesShareKRXDART:20250404003603Canonical exit: 3 Jul 2025 (T+90)
- 251 sharesShareKRXDART:20250404003613Canonical exit: 3 Jul 2025 (T+90)
- 1,193 sharesShareKRXDART:20250108000325
- 400 sharesShareKRXDART:20250108000328Canonical exit: 8 Apr 2025 (T+90)
- 999 sharesShareKRXDART:20241106000313Canonical exit: 4 Feb 2025 (T+90)
- 727 sharesShareKRXDART:20241106000315Canonical exit: 4 Feb 2025 (T+90)
- 720 sharesKRXDART:20241025000384Canonical exit: 19 Jan 2025 (T+90)
- ShareKRXDART:20240712000370Canonical exit: 3 Oct 2024 (T+90)
- ShareKRXDART:20240531002825Canonical exit: 24 Jun 2024 (T+90)
- 1,485 shares@ ₩17,792.0099.6% of flowShareKRXDART:20240503000654Canonical exit: 29 Jul 2024 (T+90)
25 of 99 declarations
About Celltrion Pharm, Inc.
On March 24, 2026, 셀트리온 filed a purchase of EUR 15.7 million at Celltrion Pharm, Inc. (셀트리온제약), nearly the whole of the amounts recorded: 19 of the 39 purchases carry an amount, EUR 15.7 million in all, with a median of just EUR 55. The next are EUR 17,861 for 우영제 on April 30, 2024 and EUR 9,797 for 최승재 on January 31, 2023.
On March 26, 2024, 10 filers bought on the same day. Across the full history, 18 purchase filings are classed as clustered. 셀트리온 accounts for 62 of the 99 filings, 11 of them purchases, and three executives, 최승재 (수석부사장), 최덕규 (전무) and 김주범 (상무), each filed 4 times, all purchases. The record counts 39 purchases and 4 sales, 91% purchases.
Read moreShow less
Insiders, 16 filers, hold 55.3% of this health care company, valued at KRW 1.6 trillion. Filings were published from March 11, 2021 to April 10, 2026, and reached 21 in 2022 and 2024 before falling to 7 in 2025. In the last 12 months there are 12 filings, 10 purchases and 1 sale. Median publication delay, all filings: 10 days.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
